Back to Home
Free On-DemandOnline Article

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

Release Date

December 19, 2025

Expiration Date

December 20, 2026

Credits

2.0 On-Demand

Topics

Genitourinary Cancer, Men's Health+1 more

Program Description

Prostate cancer is the most common disease burdening men across the United States, and it is the second leading cause of cancer-related deaths in men. In recent years, the use of anti-androgen therapy has been shown to be effective in clinical trials with use alongside PARP inhibitors. Earlier addition of anti-androgen therapy has been employed to mitigate mortality associated with metastatic castration-resistant prostate cancer (mCRPC). Yet, rates of prostate cancer are continuing to rise due to health disparities across the United States, such as socioeconomic challenges, environmental exposures, and genetic factors. Recognizing potential signs and symptoms of prostate cancer is key to implementing more timely treatment for patients at heightened risk and ensuring that treatment selection is personalized based on patient preference, molecular testing, and accessibility. The activity will review emerging research in cost-effective prostate cancer treatment through the optimization of guideline-directed medical therapies. Key points within this article will support managed care pharmacists in advocating for adherence to medications as well as access to cost-effective regimens to appropriately treat the condition and enhance men’s quality of life.

Target audience: Managed care pharmacists, oncology pharmacists

Type of activity: Application
Release date: December 1, 2025
Expiration date: December 19, 2026
Learner level: Foundational, Intermediate
Time to complete activity: 2.0 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

  • Assess the evolving treatment landscape for prostate cancer and the use of molecular testing in personalizing therapy to optimize patient outcomes
  • Provide recent clinical and safety evidence for novel and emerging treatments, including anti-androgens, PARP inhibitors, and combination regimens for prostate cancer
  • Investigate the economic considerations of advanced prostate cancer therapies and strategies to improve access, optimize outcomes, and manage costs in the context of managed care

    Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

    GET STARTED WITH THIS PROGRAM:

    Register now to gain access to this program.

    Create AccountAlready Registered? Login Here

    This activity is supported by an independent educational grant from Astellas and Pfizer, Inc.

    What's Included
    • Access your activities anytime, anywhere, with a computer, tablet or smartphone
    • Free access with a PTCE account
    • Pharmacy education designed to improve patient care

    Related Content

    Course

    Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

    Create Account